Literature DB >> 1294529

Induction of an invasive phenotype in benign tumor cells with a laminin A-chain synthetic peptide.

L S Royce1, G R Martin, H K Kleinman.   

Abstract

K-1735 clones 10 and M2 are cell lines cloned from a UV-induced murine melanoma. While both lines are highly tumorigenic, only the M2 cells are highly invasive in vitro and metastatic in vivo. Here we have exposed the clone 10 cells to the synthetic peptide PA22-2, which contains the IKVAV sequence from the A chain of laminin and which, like laminin, induces collagenase IV production and enhances metastasis formation by B16F10 cells. Zymogram analysis of conditioned media from clone 10 cells cultured on the peptide demonstrated a dose-dependent increase in collagenase IV activity. When clone 10 cells were cultured on a reconstituted basement membrane (Matrigel), this peptide caused an invasive phenotype comparable to the M2 cells. The invasive clone 10 cells were, however, unable to form lung colonies in vivo in the presence of this peptide. We conclude that this peptide represents an active site on laminin which is able to stimulate the invasiveness of this tumor cell line, but that this activity is not sufficient to confer metastatic potential.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1294529

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  2 in total

1.  SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathway.

Authors:  Vanessa M Freitas; Vanessa F Vilas-Boas; Daniel C Pimenta; Vania Loureiro; Maria A Juliano; Márcia R Carvalho; João J V Pinheiro; Antonio C M Camargo; Anselmo S Moriscot; Matthew P Hoffman; Ruy G Jaeger
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

Review 2.  Laminin-111-derived peptides and cancer.

Authors:  Yamato Kikkawa; Kentaro Hozumi; Fumihiko Katagiri; Motoyoshi Nomizu; Hynda K Kleinman; Jennifer E Koblinski
Journal:  Cell Adh Migr       Date:  2012-12-21       Impact factor: 3.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.